PubRank

N S Stuart

Author PubWeight™ 19.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 1992 2.91
2 Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee. J Natl Cancer Inst 1993 2.22
3 Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993 1.49
4 Barriers to following dietary recommendations in Type 2 diabetes. Diabet Med 2005 1.49
5 Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 1986 1.09
6 Changing character of cervical cancer in young women. BMJ 1989 1.09
7 Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites. Br J Cancer 1993 0.98
8 Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. Anticancer Drugs 1999 0.98
9 More money is needed to care for patients with cancer. BMJ 1997 0.93
10 Phase II evaluation of mitozolomide in ovarian cancer. Br J Cancer 1988 0.92
11 Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites. Eur J Cancer 1993 0.86
12 B cell production in adult rats. Adv Exp Med Biol 1985 0.82
13 ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group. J Clin Oncol 1994 0.81
14 A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy. Cancer Res 1993 0.78
15 Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non-Hodgkin's lymphoma. J Pathol 1989 0.77
16 Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group. Ann Oncol 1998 0.76
17 The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. Br J Cancer 1989 0.75
18 The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer. Br J Obstet Gynaecol 1989 0.75
19 Phase II study of Zoladex depot in advanced prostatic cancer with special reference to criteria of response and survival. Br J Urol 1987 0.75
20 Evaluating new drugs as first treatment in patients with small-cell carcinoma: guidelines for an ethical approach with implications for other chemotherapy-sensitive tumors. J Clin Oncol 1988 0.75